prasinezumab
roche
[]
exploratory analyses indicated that prasinezumab may be able to slow motor symptom progression among early stage parkinson's disease patients 
We exist to bring you science, research and clinical news about Parkinson's disease. We are a free digital publication dedicated to the patient community.